Elizabeth Comen

4.6k total citations · 1 hit paper
46 papers, 2.1k citations indexed

About

Elizabeth Comen is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth Comen has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth Comen's work include Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Elizabeth Comen is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Elizabeth Comen collaborates with scholars based in United States, Canada and United Kingdom. Elizabeth Comen's co-authors include Larry Norton, Tari A. King, Robert Benezra, Zvi Granot, Erik Henke, Joan Massagué, Mark E. Robson, Clifford A. Hudis, Jeffrey J. Kirshner and George W. Sledge and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Blood.

In The Last Decade

Elizabeth Comen

45 papers receiving 2.1k citations

Hit Papers

Tumor Entrained Neutrophils Inhibit Seeding in the Premet... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Comen United States 20 968 871 569 513 324 46 2.1k
Taher Al‐Tweigeri Saudi Arabia 24 1.7k 1.8× 553 0.6× 729 1.3× 619 1.2× 183 0.6× 61 2.5k
Volker Möbus Germany 26 1.2k 1.2× 587 0.7× 276 0.5× 493 1.0× 231 0.7× 117 2.2k
Jean‐Sébastien Frenel France 26 1.4k 1.4× 708 0.8× 350 0.6× 801 1.6× 284 0.9× 188 2.7k
Christoph Domschke Germany 23 835 0.9× 494 0.6× 491 0.9× 261 0.5× 253 0.8× 64 1.6k
Kyle C. Strickland United States 20 957 1.0× 343 0.4× 406 0.7× 485 0.9× 413 1.3× 72 2.2k
Changping Wu China 25 1.3k 1.3× 599 0.7× 619 1.1× 673 1.3× 309 1.0× 58 2.4k
Simone Reu Germany 20 1.2k 1.3× 394 0.5× 285 0.5× 826 1.6× 330 1.0× 53 2.2k
Yinghui Guan China 22 876 0.9× 1.1k 1.3× 469 0.8× 1.5k 2.8× 186 0.6× 54 2.6k
Lorena Incorvaia Italy 24 910 0.9× 481 0.6× 247 0.4× 602 1.2× 225 0.7× 113 1.9k
Ryusuke Murakami Japan 19 1.2k 1.3× 393 0.5× 952 1.7× 606 1.2× 172 0.5× 78 2.3k

Countries citing papers authored by Elizabeth Comen

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Comen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Comen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Comen more than expected).

Fields of papers citing papers by Elizabeth Comen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Comen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Comen. The network helps show where Elizabeth Comen may publish in the future.

Co-authorship network of co-authors of Elizabeth Comen

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Comen. A scholar is included among the top collaborators of Elizabeth Comen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Comen. Elizabeth Comen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Comen, Elizabeth, Sadna Budhu, Yuval Elhanati, et al.. (2024). Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer. iScience. 27(2). 108880–108880. 5 indexed citations
3.
Brooks, Jennifer D., Elizabeth Comen, Anne S. Reiner, et al.. (2018). CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Research. 20(1). 149–149. 17 indexed citations
4.
Comen, Elizabeth, Robert L. Bowman, & Maria Kleppe. (2018). Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. Frontiers in Cell and Developmental Biology. 6. 56–56. 62 indexed citations
5.
Scott, Jessica M., Neil M. Iyengar, Tormod S. Nilsen, et al.. (2018). Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial. Cancer. 124(12). 2552–2560. 85 indexed citations
6.
Recht, Abram, Elizabeth Comen, Richard E. Fine, et al.. (2016). Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Practical Radiation Oncology. 6(6). e219–e234. 129 indexed citations
7.
Recht, Abram, Elizabeth Comen, Richard E. Fine, et al.. (2016). Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Annals of Surgical Oncology. 24(1). 38–51. 83 indexed citations
8.
Comen, Elizabeth, Venkatraman Seshan, Riddhi Shah, et al.. (2016). TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. npj Breast Cancer. 2(1). 16009–16009. 31 indexed citations
9.
Smyth, Lillian M., Neil M. Iyengar, Sujata Patil, et al.. (2016). Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study. Breast Cancer Research and Treatment. 158(1). 91–97. 20 indexed citations
10.
Iyengar, Neil M., Monica Fornier, Steven Sugarman, et al.. (2015). A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clinical Breast Cancer. 16(2). 87–94. 2 indexed citations
11.
Kleppe, Maria, Elizabeth Comen, Hannah Y. Wen, et al.. (2015). Somatic mutations in leukocytes infiltrating primary breast cancers. npj Breast Cancer. 1(1). 15005–15005. 37 indexed citations
12.
Newton, Paul N., Jeremy Mason, Maxine S. Jochelson, et al.. (2015). Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites. npj Breast Cancer. 1(1). 15018–15018. 35 indexed citations
13.
Price, Elissa R., Jennifer D. Brooks, Elizabeth Watson, et al.. (2013). The Impact of Bilateral Salpingo-Oophorectomy on Breast MRI Background Parenchymal Enhancement and Fibroglandular Tissue. European Radiology. 24(1). 162–168. 29 indexed citations
14.
Comen, Elizabeth, Patrick G. Morris, & Larry Norton. (2012). Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 17(3-4). 241–249. 9 indexed citations
15.
Granot, Zvi, Erik Henke, Elizabeth Comen, et al.. (2011). Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung. Cancer Cell. 20(3). 300–314. 601 indexed citations breakdown →
16.
Comen, Elizabeth, Larry Norton, & Joan Massagué. (2011). Clinical implications of cancer self-seeding. Nature Reviews Clinical Oncology. 8(6). 369–377. 227 indexed citations
17.
Comen, Elizabeth, Mithat Gönen, Ana Dutra-Clarke, et al.. (2010). Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Research and Treatment. 127(2). 479–487. 14 indexed citations
18.
Comen, Elizabeth & Monica Fornier. (2010). Algorithms for the Treatment of Patients With Metastatic Breast Cancer and Prior Exposure to Taxanes and Anthracyclines. Clinical Breast Cancer. 10. S7–S19. 4 indexed citations
19.
Comen, Elizabeth & Mark E. Robson. (2010). Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer.. PubMed. 24(1). 55–62. 37 indexed citations
20.
Blanco, Paola G., Steven D. Freedman, Mario Ollero, et al.. (2004). Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses. American Journal of Obstetrics and Gynecology. 190(5). 1369–1374. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026